words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

Innovative Medicine Made Accessible to Those in Need

Our Story

Latest News

Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Care Gene Therapy Post
Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets*
TGCnews2
Juniper Biologics Acquires Cell-Mediated Gene Therapy TG-C LD For Treatment of Knee Osteoarthritis
Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Grandma
Juniper Biologics In-Licenses Helsinn’s Oncology Portfolio For Aloxi®, Onicit®, Paloxi®, Akynzeo® and Anamorelin (INN)
ceoraman
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive